Cryopreservation of semen from pubertal boys with cancer.

BACKGROUND The possibility of cryopreservation of semen from adolescents has until now received only little attention. Therefore, we have investigated the possibility of cryopreservation of semen in adolescent boys with cancer. PROCEDURE Forty-five boys, aged 13-18 years, admitted because of cancer during the period January 1, 1995 to July 31, 1998 were eligible. Semen was obtained after masturbation in the majority of the cases. In three boys, semen was preserved after penile vibration or electroejaculation in general anaesthesia. The semen samples were analysed for concentration, motility, and morphology according to the WHO guidelines. The sample was transferred into straws prior to cryopreservation at 196 degrees C in liquid nitrogen. RESULTS Twenty-one boys delivered a semen sample for cryopreservation. Four boys were offered and accepted sperm banking but were not able to produce a sample. In 20 cases time did not allow an attempt of sperm banking, the boy was not assessed to be mature enough to deliver a semen sample, or the procedure was not accepted. The boys delivered 1-3 samples, and the total number of spermatozoa ranged from 0-210 millions. Median percentage of motile sperm was 50% (range 9-86%). Semen quality improved with age; however, a 13- year- old boy produced 75 million spermatozoa with 38% motile cells. CONCLUSIONS Pubertal maturation should be assessed in all boys admitted for cancer, and the possibility of sperm banking should be discussed with the patient and his parents.

[1]  S. Shalet,et al.  Gonadal damage from chemotherapy and radiotherapy. , 1998, Endocrinology and metabolism clinics of North America.

[2]  K. Schmiegelow,et al.  Penile Vibratory Stimulation and Electroejaculation Before Anticancer Therapy in Two Pubertal Boys , 1998, Journal of pediatric hematology/oncology.

[3]  A. Agarwal,et al.  Cryopreservation of Gametes in Young Patients With Cancer , 1998, Journal of pediatric hematology/oncology.

[4]  E. Puscheck,et al.  Reproductive sequelae of cancer treatment. , 1998, Obstetrics and gynecology clinics of North America.

[5]  T. K. Jensen,et al.  Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. , 1997, The Journal of clinical endocrinology and metabolism.

[6]  C. Sklar Growth and neuroendocrine dysfunction following therapy for childhood cancer. , 1997, Pediatric clinics of North America.

[7]  S. Ziebe,et al.  Results of intracytoplasmic sperm injection in relation to indication , 1997, Acta obstetricia et gynecologica Scandinavica.

[8]  A. Agarwal,et al.  Effects of cancer on spermatozoa quality after cryopreservation: a 12-year experience. , 1997, Fertility and sterility.

[9]  S. Shalet Endocrine sequelae of cancer therapy. , 1996, European journal of endocrinology.

[10]  T. K. Jensen,et al.  Semen quality among members of organic food associations in Zealand, Denmark , 1996, The Lancet.

[11]  E. Nieschlag,et al.  Cryopreservation of semen from adolescent patients with malignancies. , 1996, Medical and pediatric oncology.

[12]  Z. Rosenwaks,et al.  Intracytoplasmic sperm injection: a novel treatment for all forms of male factor infertility. , 1995, Fertility and sterility.

[13]  N. Keiding,et al.  Onset of the release of spermatozoa (spermarche) in boys in relation to age, testicular growth, pubic hair, and height. , 1986, The Journal of clinical endocrinology and metabolism.